DexCom's recent licensing deal with Nanowear is likely to reinforce the broader potential of CGMs in continuous metabolic ...

DexCom DXCM recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use ...

as the company announced a significant integration of its G7 Continuous Glucose Monitoring Systems with Nanowear's SimpleSense platform, which is expected to advance cardiometabolic diagnostics.

Aura, an AI-enabled digital protection platform, announced it officially closed its Series G funding round, raising $140 million in equity and debt and bringing its valuation to $1.6 billion. The ...

EpiWatch, the Apple Watch-based epilepsy management company spun out from Johns Hopkins, announced it received FDA 510(k) clearance for its continuous seizure monitor platform that utilizes the ...